GOP committee leaders skeptical of Trump's bid to overhaul Medicare drug rebates
Washington Examiner -

House and Senate GOP committee leaders are wary of the Trump administration’s potential move to revamp drug rebates in Medicare, which administration officials believe are the reason for higher drug prices.

Loading...

Related Articles